A microbial signature for Crohn's disease

Area of Science:

• Microbiome research
• Gastroenterology
• Immunology

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is linked to gut microbiome alterations in genetically susceptible individuals.
• Existing studies on IBD gut microbiome dysbiosis lack consistency and fail to identify specific microbial signatures for CD and UC.
• There is a need to compare the fecal microbiome of CD patients, UC patients, and non-IBD individuals to establish distinct microbial profiles.

Purpose of the Study:

• To compare the fecal microbiome composition in patients with CD, UC, and non-IBD subjects.
• To identify potential microbial signatures that can differentiate between CD and UC.
• To establish distinct microbiome-level classifications for IBD subtypes.

Main Methods:

• Analysis of 2045 fecal samples from non-IBD and IBD patients across Spain, Belgium, the UK, and Germany.
• Application of 16S rRNA sequencing technology to a dataset of 115 million sequences.
• Longitudinal study design to track microbiome changes over time.

Main Results:

• Dysbiosis was significantly more pronounced in CD patients compared to UC patients, characterized by reduced microbial diversity and community stability.
• Eight microbial groups were identified as a specific microbial signature for CD.
• The proposed CD signature demonstrated high sensitivity (80%) and specificity (94-91%) in distinguishing CD from healthy controls and other conditions, including UC.

Conclusions:

• Despite shared features, UC and CD represent distinct subtypes of IBD at the microbiome level.
• The study proposes the first microbiomarkers capable of discriminating between CD and non-CD, independent of geographical origin.
• These findings advance the understanding of IBD pathogenesis and offer potential for improved diagnostics.